Can a patient with an allergy to Augmentin (amoxicillin‑clavulanate) be treated with ertapenem?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient with Augmentin Allergy Receive Ertapenem?

Yes, a patient with an Augmentin (amoxicillin-clavulanate) allergy can safely receive ertapenem without prior testing or additional precautions in most cases. 1

Evidence-Based Rationale

Extremely Low Cross-Reactivity Between Penicillins and Carbapenems

  • The risk of cross-reactivity between penicillins (including amoxicillin) and carbapenems is remarkably low at 0.87% (95% CI: 0.32-2.32%) based on a systematic review of 1,127 penicillin-allergic patients. 1, 2

  • Among patients with positive penicillin skin tests (n=295), only 1 patient (0.3%; 95% CI: 0.06%-1.9%) had a reaction to carbapenems with symptoms consistent with a potentially IgE-mediated mechanism. 1

  • A prospective study of 211 patients with skin test-confirmed penicillin allergy demonstrated that all patients tolerated carbapenems without any reactions. 1

Current Guideline Recommendations

The 2022 Journal of Allergy and Clinical Immunology practice parameter provides a conditional recommendation (moderate certainty of evidence) that carbapenems may be administered to patients with penicillin or cephalosporin allergy without testing or additional precautions. 1

  • This recommendation applies to patients with histories of penicillin allergy, as long as it is not a severe delayed cutaneous or organ-involved reaction. 1

  • The Dutch Working Party on Antibiotic Policy (SWAB) 2023 guideline similarly supports carbapenem use in patients with suspected immediate-type penicillin allergy without additional measures. 3

FDA Labeling Considerations

The FDA label for ertapenem does note that "there have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe hypersensitivity reactions when treated with another beta-lactam," and recommends careful inquiry about previous hypersensitivity reactions. 4

However, this is a general precautionary statement for all beta-lactams and does not contraindicate use—it simply advises vigilance.

Clinical Algorithm for Administration

When to Give Ertapenem Directly (No Testing Required):

  • Any non-severe immediate reaction to Augmentin (e.g., urticaria, mild rash) 1
  • Any delayed non-severe reaction to Augmentin (e.g., maculopapular rash occurring >1 hour after administration) 1
  • Remote history of Augmentin allergy (occurred years ago with unclear details) 1

When to Consider Additional Precautions:

  • Severe delayed cutaneous reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome) - carbapenems should be avoided entirely in these cases 1
  • Multiple drug allergies or significant patient anxiety - consider a graded drug challenge rather than full-dose administration 1
  • History of anaphylaxis to Augmentin - while carbapenems can still be used, some clinicians may prefer a graded challenge in a monitored setting 1

Important Caveats

Clavulanate-Specific Allergy

  • Recent evidence shows that clavulanate (the clavulanic acid component of Augmentin) is itself a leading culprit in immediate allergic reactions, accounting for 32.7% of confirmed immediate reactions to amoxicillin-clavulanate. 5

  • If the patient's allergy is specifically to clavulanate rather than amoxicillin, ertapenem is an excellent alternative as it contains no clavulanate. 5

  • Conversely, if the allergy is confirmed to be to the amoxicillin component only, the cross-reactivity risk with ertapenem remains <1%. 1, 2

Monitoring Recommendations

  • While testing is not required, administration should occur in a setting where rapid treatment of allergic reactions is available, particularly for the first dose. 4

  • Patients should be monitored for at least 30-60 minutes after the first dose for signs of immediate hypersensitivity. 4

Research Evidence Supports Safety

  • A study of 49 patients with confirmed IgE-mediated beta-lactam allergy (positive skin tests) showed that 35 of 36 patients (97.2%) who underwent challenge tolerated the full dose of ertapenem. 6

  • Another study of 212 consecutive subjects with immediate reactions to penicillins and positive skin tests showed that 211 accepted carbapenem challenges and all tolerated them. 7

The practice of routinely avoiding carbapenems in patients with penicillin or Augmentin allergy should be abandoned given the very low cross-reactivity rate and strong supporting evidence. 1, 6, 7

References

1
Guideline

drug allergy: a 2022 practice parameter update.

Journal of Allergy and Clinical Immunology, 2022

6
Research

Cross-reactivity and Tolerability of Ertapenem in Patients With IgE-Mediated Hypersensitivity to β-Lactams.

Journal of investigational allergology & clinical immunology, 2016

Related Questions

Can ertapenem be used in a patient with an amoxicillin (amoxicillin) allergy?
Can a patient with a sulfonamide (sulfa) allergy safely take Augmentin (amoxicillin + clavulanate)?
Can I substitute a 250 mg/62.5 mg per mL amoxicillin‑clavulanate suspension for the prescribed 125 mg/31.25 mg per 5 mL formulation, and how should the dose be adjusted?
What is the appropriate dosing of Augmentin (amoxicillin/clavulanate) suspension 200 mg amoxicillin + 28.5 mg clavulanate per 5 mL for a 15‑kg child?
How should I manage an elderly patient with a six‑week productive cough, poor oral intake, and diarrhea after a five‑day course of amoxicillin‑clavulanate (Augmentin)?
When is an elevated serum calcium level clinically significant and warrants intervention?
Can a repeat loading dose of antithyroid medication be given for thyroid storm if a loading dose was administered the day before?
What is the appropriate diagnostic work‑up and initial management for a 30‑year‑old with gross hematuria, low urine specific gravity, normal pH, red urine, trace leukocyte esterase, 1+ protein, 3+ occult blood, negative nitrite and no microscopic analysis (reflexed to culture)?
In an 83‑year‑old male with stage 3a chronic kidney disease, systolic heart failure, pre‑diabetes, and current therapy including torsemide, is it reasonable to add empagliflozin (Jardiance) to his regimen, and should any medication adjustments be made?
In a healthy patient in their late 80s or older with osteoporosis and stable bone mineral density, how long can Prolia (denosumab) be administered?
Can I take Chantix (varenicline) with Lamictal (lamotrigine), Lexapro (escitalopram), gabapentin, and Wellbutrin (bupropion)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question